REGENXBIO Inc. (RGNX)
NASDAQ·Healthcare·Biotechnology
$8.45
+22.51%
Mkt Cap $365.50M
Analyst Ratings
Buy
10
Hold
1
Sell
0
Price Target (22 analysts)
$22.50
Range $12.00 – $45.00
Implied Upside
+166.3%
Consensus $22.50 vs current $8.45
NASDAQ·Healthcare·Biotechnology
$8.45
+22.51%
Mkt Cap $365.50M
Buy
10
Hold
1
Sell
0
Price Target (22 analysts)
$22.50
Range $12.00 – $45.00
+166.3%
Consensus $22.50 vs current $8.45